Federico Chinni new managing director of UCB Italia. ::. P

0
20


From November 1, 2019, Federico Chinni is the new CEO of UCB Italia, a biopharmaceutical company that develops innovative solutions for the treatment of serious diseases in the areas of immunology and neurology.

From November 1, 2019, Federico Chinni is the new CEO of UCB Italia, a biopharmaceutical company that develops innovative solutions for the treatment of serious diseases in the areas of immunology and neurology."It is a great honor for me to take the lead in our branch" – he declares Federico Chinni. "Like UCB Italia, we will have to contribute to the fascinating challenge of 6 launches in 6 years at a global level, a challenge that we can only win by working together, with a model based on agility in the decision-making process and on the transversality of skills and roles."

Born in 1971, married, 2 daughters, Federico Chinni graduated in Law from the University of Bologna. He has gained a twenty-year professional career in multinational companies, first at leading companies in the biomedical sector and then, from 2012, in the pharmaceutical sector, where he held managerial roles of increasing responsibility, both nationally and internationally. In UCB from 2018, he served as director of the neurology division until his promotion.

The appointment of Federico Chinni takes place at a particularly positive moment for UCB: “The news of the positive opinion of the Chmp on romosozumab and that of the phase III results of bimekizumab, which open really promising scenarios for the affected patients, are from a few days ago respectively, from fragility fractures and psoriasis ", says Chinni.



Source link
https://www.pharmastar.it/news/business/federico-chinni-nuovo-amministratore-delegato-di-ucb-italia-30791

Dmca

LEAVE A REPLY

Please enter your comment!
Please enter your name here

9 + 6 =